日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial

地诺单抗作为HER2阴性早期乳腺癌的免疫调节剂:D-BIOMARK临床试验的窗口期结果

Vethencourt, Andrea; Trinidad, Eva M; Dorca, Eduard; Petit, Anna; Soler-Monsó, M Teresa; Ciscar, Marina; Barranco, Alexandra; Pérez-Chacón, Gema; Jimenez, María; Rodríguez, Mario; Gomez-Aleza, Clara; Purqueras, Elvira; Hernández-Jiménez, Enrique; Urruticoechea, Ander; Morilla, Idoia; Subirana, Isaac; García-Tejedor, Amparo; Gil-Gil, Miguel; Pernas, Sonia; Falo, Catalina; Gonzalez-Suarez, Eva

Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease

乳腺癌患者接受新辅助化疗和手术后5年和10年(II-III期)的预后

Falo, Catalina; Azcarate, Juan; Fernandez-Gonzalez, Sergi; Perez, Xavier; Petit, Ana; Perez, Héctor; Vethencourt, Andrea; Vazquez, Silvia; Laplana, Maria; Ales, Miriam; Stradella, Agostina; Fullana, Bartomeu; Pla, Maria J; Gumà, Anna; Ortega, Raul; Varela, Mar; Pérez, Diana; Ponton, Jose Luis; Cobo, Sara; Benitez, Ana; Campos, Miriam; Fernández, Adela; Villanueva, Rafael; Obadia, Veronica; Recalde, Sabela; Soler-Monsó, Teresa; Lopez-Ojeda, Ana; Martinez, Evelyn; Ponce, Jordi; Pernas, Sonia; Gil-Gil, Miguel; Garcia-Tejedor, Amparo

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

新辅助治疗后前哨淋巴结阳性乳腺癌患者腋窝淋巴结清扫术与放射治疗的比较(ADARNAT试验)

Garcia-Tejedor, Amparo; Ortega-Exposito, Carlos; Salinas, Sira; Luzardo-González, Ana; Falo, Catalina; Martinez-Pérez, Evelyn; Pérez-Montero, Héctor; Soler-Monsó, M Teresa; Bajen, Maria-Teresa; Benitez, Ana; Ortega, Raul; Petit, Anna; Guma, Anna; Campos, Miriam; Plà, Maria J; Pernas, Sonia; Peñafiel, Judith; Yeste, Carlos; Gil-Gil, Miguel; Guedea, Ferran; Ponce, Jordi; Laplana, Maria

Modification of BRCA1-associated breast cancer risk by HMMR overexpression

HMMR 过表达可改变 BRCA1 相关乳腺癌风险

Francesca Mateo #, Zhengcheng He #, Lin Mei #, Gorka Ruiz de Garibay, Carmen Herranz, Nadia García, Amanda Lorentzian, Alexandra Baiges, Eline Blommaert, Antonio Gómez, Oriol Mirallas, Anna Garrido-Utrilla, Luis Palomero, Roderic Espín, Ana I Extremera, M Teresa Soler-Monsó, Anna Petit, Rong Li, Joa

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

抗 HER2 治疗后 RANK 信号增强,导致 HER2 阳性乳腺癌产生耐药性

Adrián Sanz-Moreno #, Sonia Palomeras #, Kim Pedersen #, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A Rakha, Andrew R Green, Patricia G S